Study: Schorr 2012, Journal of Drugs in Dermatology
Adjunctive use of a facial moisturizer SPF 30 containing ceramide precursor improves tolerability of topical tretinoin 0.05%: a randomized, investigator-blinded, split-face study
Citation
Schorr ES, Sidou F, Kerrouche N, et al (2012). Journal of Drugs in Dermatology. PubMed id 23135655.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Skincare order and layering Tier B thin
B Adults with healthy skin (number not given in the abstract) (n=not stated)
Randomised, investigator-blinded, split-face study: tretinoin 0.05% cream to the whole face once daily, plus an SPF 30 ceramide moisturiser (a marketed product) once daily to one randomised side.
About 83% to 86% of people had irritation on both sides, mostly mild on the moisturiser side. Tolerability preferences favoured the moisturiser plus tretinoin side, and the authors concluded the moisturiser improved tolerance of tretinoin.
As recorded in this card: Schorr ES, Sidou F, Kerrouche N, et al (2012), Journal of Drugs in Dermatology, [primary]
Note: Marketed product, probably industry-run; funding not checked. It tested adding a moisturiser, not the order of application; ancestry not given.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.